NORFOLK Va. – Thirteen-year-old Alanna of Norfolk is able to roll up her sleeve once Pfizer’s COVID-19 vaccine is authorized for youngsters as younger as 12.
Her mom, Kathy Blanchard, mentioned the shot would give the teen peace of thoughts.
“She would be much more comfortable going out and doing things,” Blanchard mentioned. “She’s worried when we go out because she’s a germaphobe, so yes, she would definitely take it because she would feel protected.”
The COVID-19 vaccine is at the moment authorized for youngsters as younger as 16, however with the greenlight from the FDA just days away, those aged 12 to 15 years old may begin getting the shot as early as the top of the month.
“We’ve seen some good news come out recently from Pfizer that their trials among 12- to15-year-olds have shown really promising results in terms efficacy and safety,” mentioned Dr. Danny Avula, who leads Virginia’s COVID-19 vaccination program.
Dr. Avula mentioned immunizing youthful folks is essential as COVID-19 circumstances among the many younger and unvaccinated proceed to rise.
“That’s concerning on one hand because even though they’re not necessarily going to suffer more severe consequences of COVID because younger and healthy people typically don’t, they will continue to spread COVID to pockets of our population who have chosen not to be vaccinated,” he mentioned.
According to Avula, the state Department of Health plans on teaming up with center colleges to assist vaccinate that age group, bringing the Commonwealth one step nearer to herd immunity hopefully by late summer time.
For Blanchard, Pfizer’s drug is a sport changer and shortly, she’ll now not fear about her little one getting coronavirus.
“It’s been proven safe on adults, and I know that they would not use it for the children unless it has gone through the proper channels and approval,” mentioned Blanchard. “Technology is so advanced; I don’t understand everybody’s fear of not wanting to provide the proper healthcare and security for themselves and their children.”
In the meantime, Moderna is anticipated to launch information from its vaccine trial involving teenagers as younger as 12 quickly.